Amber Salzman

Amber Salzman

Director Ejecutivo en
Epicrispr Biotechnologies, Inc.
.
64 años
Health Technology
Consumer Services
Commercial Services

Perfil

Amber Salzman is the founder of Annapurna Therapeutics SAS, which was founded in 2012.
She held the title of President & Chief Executive Officer from 2012 to 2016.
Currently, she is the President, Chief Executive Officer & Director at Ohana Biosciences, Inc., the Chief Executive Officer at Epicrispr Biotechnologies, Inc., the Director at Drexel University School of Public Health, the Director at Ald Connect, Inc., a Non-Executive Director at AviadoBio Ltd., and a Trustee at Lankenau Institute for Medical Research.
She is also the President of The Stop ALD Foundation since 2001.
In her former positions, she was the President & Chief Executive Officer of CardioKine, Inc. from 2009 to 2011, the President, Chief Executive Officer & Director of Adverum Biotechnologies, Inc. from 2016 to 2018, and a Director at Akcea Therapeutics, Inc. in 2020.
She was also a Member-Research & Development Executive Team at GSK Plc.
Dr. Salzman holds a doctorate degree from Bryn Mawr College and an undergraduate degree from Temple University (Pennsylvania).

Cargos activos de Amber Salzman

EmpresasCargoInicio
Presidente 01/03/2001
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director Ejecutivo -

Antiguos cargos conocidos de Amber Salzman.

EmpresasCargoFin
AKCEA THERAPEUTICS, INC. Director/Miembro de la Junta 12/10/2020
ADVERUM BIOTECHNOLOGIES, INC. Director Ejecutivo 03/05/2018
Director Ejecutivo 01/01/2016
░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░ -
Ver el detalle de la experiencia de Amber Salzman.

Formación de Amber Salzman.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

33

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Technology

Commercial Services

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN